Viola Poeschel

3.9k citations

39 papers · 872 indexed · h-index 13

Impact in

Pathology and Forensic Medicine top 2%
- Lymphoma Diagnosis and Treatment
Genetics top 5%
- Chronic Lymphocytic Leukemia Research

Papers in

Genetics 21
- Chronic Lymphocytic Leukemia Research 21
Pathology and Forensic Medicine 34
- Lymphoma Diagnosis and Treatment 34

Co-authors: Michael Pfreundschuh Norbert Schmitz Gerhard Held Samira Zeynalova Niels Murawski Tanja Rixecker Marita Ziepert Marcel Reiser
Journals: Journal of Clinical Oncology (13 papers)Blood (12 papers)Annals of Oncology (2 papers)International Journal of Radiation Oncology*Biology*Physics (1 paper)Pharmacogenomics (1 paper)
Partner nations: Germany France Switzerland

In The Last Decade

Viola Poeschel

36 papers receiving 861 citations

Peers

Countries citing papers authored by Viola Poeschel

Since Specialization

Citations

This map shows the geographic impact of Viola Poeschel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viola Poeschel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viola Poeschel more than expected).

Fields of papers citing papers by Viola Poeschel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Viola Poeschel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viola Poeschel. The network helps show where Viola Poeschel may publish in the future.

Co-authors

The 25 scholars most cited alongside Viola Poeschel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Viola Poeschel Line = papers co-authored together Viola Poeschel links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Comparison of R‐CHOP‐14 and R‐mini‐CHOP in older adults with diffuse large B‐cell lymphoma—A retrospective multicenter cohort study European Journal Of Haematology ·Zelal Guel Dilbaz, Sophy Denker, Carla Ankermann, Joerg‐Thomas Bittenbring, Dominic Kaddu‐Mulindwa, A. Kunte, S Hünecke, Viola Poeschel, Stephan Stilgenbauer, Lorenz Thurner, Il‐Kang Na, Moritz Bewarder, Konstantinos Christofyllakis	2024	1
2	An inherited genetic variant of the CEP72 gene is associated with the development of vincristine-induced peripheral neuropathy in female patients with aggressive B-cell lymphoma Annals of Hematology ·Konstantinos Christofyllakis, Dominic Kaddu‐Mulindwa, Vadim Lesan, Torben Rixecker, Igor Age Kos, Gerhard Held, Evi Regitz, Michael Pfreundschuh, Joerg Thomas Bittenbring, Lorenz Thurner, Viola Poeschel, Marita Ziepert, Bettina Altmann, Moritz Bewarder	2024	2
3	Radiotherapy in younger patients with advanced aggressive B-cell lymphoma—long-term results from the phase 3 R-MegaCHOEP trial Leukemia ·Michael Oertel, Marita Ziepert, Fabian Frontzek, Nina Nacke, Bettina Altmann, Maike Nickelsen, Bertram Glass, Viola Poeschel, Christian Ruebe, Georg Lenz, Norbert Schmitz, Hans Theodor Eich	2024	2
4	Impact of vincristine dose reduction on outcomes of patients with aggressive B-cell lymphoma treated with (R)-CHOP Haematologica ·Moritz Bewarder, Dominic Kaddu‐Mulindwa, Igor Age Kos, Vadim Lesan, Gerhard Held, Viola Poeschel, Lorenz Thurner, Joerg Thomas Bittenbring, Norbert Schmitz, Lorenz Truemper, Michael Pfreundschuh, Konstantinos Christofyllakis, Markus Loeffler, Bettina Altmann, Marita Ziepert	2023	2
5	Radiotherapy in Young, High-Risk Patients with Aggressive B-cell Lymphoma: Long-Term Results from the Open-Label, Randomized, Phase 3 R-MegaCHOEP Trial International Journal of Radiation OncologyBiologyPhysics ·Michael Oertel, Marita Ziepert, Nina Nacke, Fabian Frontzek, Maike Nickelsen, B. Glaß, Viola Poeschel, Christian Rübe, Georg Lenz, Norbert Schmitz, Hans Theodor Eich	2023	1
6	A Simplified IPI Including BCL2 Identifies IPI 3 Patients with Poor Prognosis - a GLA/ Dshnhl and Lysa Collaboration Blood ·Marita Ziepert, Bettina Altmann, Viola Poeschel, Caterina Cristinelli, Loïc Chartier, Nicolas Ketterer, Christian Récher, Olivier Fitoussi, Gerhard Held, Olivier Casasnovas, Corinne Haïoun, Nicolas Mounier, Hervé Tilly, Franck Morschhauser, Andreas Rosenwald, German Ott, Thierry Jo Molina, Georg Lenz, Catherine Thiéblemont, Norbert Schmitz	2023	0
7	FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma: results from the prospective, multicenter PETAL and OPTIMAL>60 trials European Journal of Nuclear Medicine and Molecular Imaging ·Dominic Kaddu‐Mulindwa, Bettina Altmann, Gerhard Held, Stephanie Angel, Stephan Stilgenbauer, Lorenz Thurner, Moritz Bewarder, Maren Schwier, Michael Pfreundschuh, Markus Löffler, Karin Menhart, Jirka Grosse, Marita Ziepert, Ken Herrmann, Ulrich Dührsen, Andreas Hüttmann, Francesco Barbato, Viola Poeschel, D. Hellwig	2021	20
8	Significant reduced loss of bone mineral density after four vs. six cycles of R-CHOP: an analysis of the FLYER-trial Leukemia & lymphoma ·Dominic Kaddu‐Mulindwa, Vadim Lesan, Christian Berdel, Stephan Stilgenbauer, Moritz Bewarder, Lorenz Thurner, Mathias Witzens‐Harig, Andreas Viardot, Martin Soekler, Ulrich Keller, Lorenz Truemper, Konstantinos Christofyllakis, Octavian Fleser, Joerg Thomas Bittenbring, Viola Poeschel, Gerhard Held, Philippe Jagoda	2021	2
9	LRPAP1 autoantibodies in mantle cell lymphoma are associated with superior outcome Blood ·Lorenz Thurner, Natalie Fadle, Joerg Thomas Bittenbring, Evi Regitz, Rita Schuck, Onur Cetin, Ariane Stuhr, Torben Rixecker, Niels Murawski, Viola Poeschel, Dominic Kaddu‐Mulindwa, Klaus‐Dieter Preuss, Stephan Stilgenbauer, Olivier Hermine, Hanneke C. Kluin‐Nelemans, Sylvia Hartmann, Martin Dreyling, Christiane Pott, Moritz Bewarder, Eva Hoster	2021	7
10	SPARC-positive macrophages are the superior prognostic factor in the microenvironment of diffuse large B-cell lymphoma and independent of MYC rearrangement and double-/triple-hit status Annals of Oncology ·Giorgio Alberto Croci, Rex Au-Yeung, Sarah Reinke, Annette M. Staiger, Karoline Koch, Ilske Oschlies, Julia Richter, Viola Poeschel, Gerhard Held, Markus Loeffler, Lorenz Trümper, Andreas Rosenwald, German Ott, Rainer Spang, Bettina Altmann, Marita Ziepert, Wolfram Klapper	2021	14
11	International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI Blood ·Amy S. Ruppert, Jesse G. Dixon, Gilles Salles, Anna Wall, David Cunningham, Viola Poeschel, Corinne Haïoun, Hervé Tilly, Hervé Ghesquières, Marita Ziepert, Jocelyne Flament, Christopher R. Flowers, Qian Shi, Norbert Schmitz	2020	199
12	Radiotherapy (RT) to bulky (B) and extralymphatic (E) disease in combination with 6xR-CHOP-14 or R-CHOP-21 in young good-prognosis DLBCL patients: Results of the 2x2 randomized UNFOLDER trial of the DSHNHL/GLA. Journal of Clinical Oncology ·Michael Pfreundschuh, Niels Murawski, Marita Ziepert, Bettina Altmann, Martin Dreyling, Peter Borchmann, Stefano Luminari, Mathias Witzens‐Harig, Judith Dierlamm, Mathias Haenel, Lorenz Truemper, Bernd Metzner, Eva Lengfelder, Ulrich Keller, Christian Ruebe, Christian Berdel, Norbert Schmitz, Gerhard Held, Viola Poeschel	2018	30
13	Radiotherapy to bulky disease PET-negative after immunochemotherapy can be spared in elderly DLBCL patients: results of a planned interim analysis of the first 187 patients with bulky disease treated in the OPTIMAL > 60 study of the DSHNHL M Pfreundschuh, Konstantinos Christofyllakis, Bettina Altmann, Marita Ziepert, Mathias Haenel, Andreas Viardot, Andreas Neubauer, Gerhard Held, Lorenz Truemper, Carl Schmidt, Lothar Kanz, Michael Hallek, N. Schmitz, Tobias Heintges, C. B. Koelbel, G Schneider, Christian Ruebe, D. Hellwig, Viola Poeschel, Niels Murawski	2017	0
14	Association of NADPH Oxidase Polymorphisms with Anthracycline-Induced Cardiotoxicity in the RICOVER-60 Trial of Patients with Aggressive CD20 ⁺ B-Cell Lymphoma Pharmacogenomics ·Annegret Reichwagen, Marita Ziepert, Markus Kreuz, Ute Gödtel‐Armbrust, Tanja Rixecker, Viola Poeschel, Mohammad R. Toliat, Peter Nürnberg, Mladen V. Tzvetkov, Shiwei Deng, Lorenz Trümper, Gerd Hasenfuß, Michael Pfreundschuh, Leszek Wojnowski	2015	46
15	Optimization of Rituximab for the Treatment of Diffuse Large B-Cell Lymphoma (II): Extended Rituximab Exposure Time in the SMARTE-R-CHOP-14 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group Journal of Clinical Oncology ·Michael Pfreundschuh, Viola Poeschel, Samira Zeynalova, Mathias Hänel, Gerhard Held, Norbert Schmitz, Andreas Viardot, Martin Dreyling, Michael Hallek, Carsten Mueller, Martin H. J. Wiesen, Mathias Witzens‐Harig, Lorenz Truemper, Ulrich Keller, Tanja Rixecker, Carsten Zwick, Niels Murawski	2014	59
16	Optimization of rituximab for the treatment of DLBCL (I): dose-dense rituximab in the DENSE-R-CHOP-14 trial of the DSHNHL Annals of Oncology ·Niels Murawski, Michael Pfreundschuh, Samira Zeynalova, Viola Poeschel, Mathias Hänel, Gerhard Held, Norbert Schmitz, Andreas Viardot, Christian Schmidt, Michael Hallek, Mathias Witzens‐Harig, Lorenz Trümper, Torben Rixecker, C. Zwick	2014	48
17	Prevalence of Anti-Citrullinated Protein Antibodies (ACPA) in Patients with Diffuse Large B-Cell Lymphoma (DLBCL): A Case-Control Study PLoS ONE ·G. Aßmann, Klara Shihadeh, Viola Poeschel, Niels Murawski, Jutta Conigliarou, Mei Fang Ong, Michael Pfreundschuh	2014	6
18	Liposomal Formulation of Vincristine Allows for Doubling the Dose Compared to Conventional Vincristine: Results of the First Futility Analysis of the OPTIMAL>60 Study of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL) Blood ·Sascha Duecker, Viola Poeschel, Anne T. Wolf, Gerhard Held, Niels Murawski, Carsten Zwick, Mathias Haenel, Andreas Viardot, Lorenz Truemper, Marita Ziepert, Michael Pfreundschuh	2014	1
19	Outcome of elderly DLBCL patients with 6xCHOP-14 and 8 rituximab (R) applications given over an extended period (SMARTE-R-CHOP-14 trial of the DSHNHL). Journal of Clinical Oncology ·Niels Murawski, Gerhard Held, Samira Zeynalova, Carsten Mueller, Viola Poeschel, Andreas Viardot, Mathias Haenel, Ulrich Keller, Marcel Reiser, Marita Ziepert, Norbert Schmitz, Michael Pfreundschuh, (unknown)	2012	1
20	The role of sex and weight on rituximab clearance and serum elimination half-life in elderly patients with DLBCL Blood ·Carsten Müller, Niels Murawski, Martin H. J. Wiesen, Gerhard Held, Viola Poeschel, Samira Zeynalova, Michael Wenger, Christina Nickenig, Norma Peter, Eva Lengfelder, Bernd Metzner, Tanja Rixecker, Carsten Zwick, Michael Pfreundschuh, Marcel Reiser	2012	186

About Viola Poeschel

Viola Poeschel is a scholar working on Genetics, Pathology and Forensic Medicine, Neurology, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 39 papers that have together received 872 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (34 papers), Chronic Lymphocytic Leukemia Research (21 papers), CNS Lymphoma Diagnosis and Treatment (14 papers), Acute Lymphoblastic Leukemia research (5 papers), Viral-associated cancers and disorders (5 papers), Lung Cancer Treatments and Mutations (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Medical Imaging Techniques and Applications (3 papers). The work is most often cited by research in Pathology and Forensic Medicine (707 citations), Genetics (269 citations), Oncology (459 citations), Neurology (236 citations) and Radiology, Nuclear Medicine and Imaging (120 citations). Viola Poeschel has collaborated with scholars based in Germany, France and Switzerland. Frequent co-authors include Michael Pfreundschuh, Norbert Schmitz, Gerhard Held, Samira Zeynalova, Niels Murawski, Tanja Rixecker, Marita Ziepert, Marcel Reiser, Martin H. J. Wiesen and Carsten Zwick. Their work appears in journals such as Journal of Clinical Oncology, Blood, Annals of Oncology, International Journal of Radiation Oncology*Biology*Physics and Pharmacogenomics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact